Skip to main content
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!
Languages
Dansk
Nederlands
English
Français
Deutsch
Italiano
Español
Kiswahili
Svenska
Search form
Search
Main menu
Home
Search
About us
Books
Category Search
Log In
Recent posts
Treatment Protocols
You are here
Home
Schwannoma
Items per page
5
10
20
40
60
100
Title
Average Rating
Management of the patient and family with neurofibromatosis 2: a consensus conference statement.
30.00%
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary
50.00%
Propolis Extract (Bio 30) Suppresses the Growth of Human Neurofibromatosis (NF) Tumor Xenografts in Mice
55.00%
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary stu
60.00%
Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase path--
60.00%
Enhanced proliferation and potassium conductance of Schwann cells isolated from NF2 schwannomas can be reduced by quinidine.
60.00%
Primary melanocytic tumor of the cerebellopontine angle mimicking a vestibular schwannoma: case report.
60.00%
Primary malignant schwannoma of the cervical plexus with melanocytic differentiation.
70.00%
The efficacy of corticosteroids in restoring hearing in patients undergoing conservative management of acoustic neuromas.'
70.00%
Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.
70.00%
Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review.
70.00%
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.
80.00%